|
Market Closed -
NSE India S.E.
07:05:10 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 616.90 INR | -3.61% |
|
+20.42% | +9.20% |
| 07-23 | Solara Active Pharma Sciences Limited, Q1 2027 Earnings Call, Jul 23, 2026 | |
| 07-23 | Solara Active Pharma Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 20.5B 214M 183M 171M 157M 295M 301M 2.03B 791M 10.27B 804M 787M 34.01B | P/E 2024 |
-2.35x | P/E 2025 | 3,792x |
|---|---|---|---|---|---|
| Enterprise Value | 28.42B 297M 254M 237M 218M 409M 417M 2.81B 1.1B 14.24B 1.12B 1.09B 47.15B | EV / Sales 2024 |
1.76x | EV / Sales 2025 | 2.54x |
| Free-Float |
47.76% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Solara Active Pharma Sciences Limited
| 1 day | -3.61% | ||
| 1 week | +20.42% | ||
| Current month | +20.12% | ||
| 1 month | +10.40% | ||
| 3 months | +9.33% | ||
| 6 months | +30.62% | ||
| Current year | +9.20% |
| 1 week | 501.95 | 654.4 | |
| 1 month | 471.55 | 654.4 | |
| Current year | 422 | 654.4 | |
| 1 year | 422 | 712 | |
| 3 years | 286 | 882.8 | |
| 5 years | 286 | 1,749 | |
| 10 years | 134.5 | 1,859.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sandeep Rao
CEO | Chief Executive Officer | - | 2025-02-20 |
Sarat Kumar
DFI | Director of Finance/CFO | - | 2025-02-20 |
Pooja Jaya Kumar
CMP | Compliance Officer | - | 2025-05-14 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2018-04-10 | |
| Director/Board Member | 58 | 2018-04-10 | |
| Director/Board Member | 75 | 2023-11-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/14/25 | Buy | Director | 1,000 | 0.0021% | ||
| 3/6/25 | Pronomz Ventures LLP
| Buy | Company | 13,600 | 0.0283% | |
| 3/4/25 | Pronomz Ventures LLP
| Buy | Company | 216,361 | 0.4503% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.61% | +20.42% | -2.16% | +75.11% | 322M | ||
| -2.81% | +2.93% | +76.40% | +127.73% | 1,109B | ||
| -2.21% | +2.02% | +49.50% | +55.01% | 644B | ||
| -1.56% | +4.39% | +25.19% | +74.39% | 463B | ||
| -1.20% | +3.38% | +39.85% | +44.36% | 371B | ||
| -1.00% | +2.21% | +21.66% | +39.04% | 301B | ||
| -0.47% | +5.00% | -0.13% | +12.73% | 256B | ||
| -1.95% | +3.80% | +46.31% | +65.66% | 234B | ||
| -0.08% | +0.53% | -16.81% | -53.02% | 205B | ||
| -2.82% | +3.84% | +20.81% | +89.04% | 178B | ||
| Average | -0.79% | +5.05% | +26.06% | +53.00% | 376.14B | |
| Weighted average by Cap. | -0.16% | +3.26% | +42.72% | +70.03% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 12.89B 135M 115M 108M 98.74M 186M 189M 1.28B 498M 6.46B 506M 495M 21.39B | 12.84B 134M 115M 107M 98.35M 185M 188M 1.27B 496M 6.43B 504M 493M 21.3B |
| Net income | -5.67B -59.3M -50.77M -47.37M -43.47M -81.68M -83.28M -562M -219M -2.84B -223M -218M -9.41B | 5.4M 56.44K 48.32K 45.08K 41.37K 77.73K 79.26K 535K 208K 2.71M 212K 207K 8.96M |
| Net Debt | 9.3B 97.2M 83.22M 77.65M 71.25M 134M 137M 921M 359M 4.66B 365M 357M 15.43B | 7.92B 82.79M 70.88M 66.13M 60.68M 114M 116M 785M 306M 3.97B 311M 304M 13.14B |
Employees
1,775
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-21 | ₹616.90 | -3.61% | 732,550 |
| 26-08-20 | ₹640.00 | +16.35% | 6,915,687 |
| 26-08-19 | ₹550.05 | +0.18% | 121,098 |
| 26-08-18 | ₹549.05 | +7.85% | 673,349 |
| 26-08-17 | ₹509.10 | -0.62% | 75,893 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SOLARA Stock
Select your edition
All financial news and data tailored to specific country editions

















